Marvin 03071215142D 23 24 0 0 1 0 999 V2000 10.6102 -5.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.6102 -4.4692 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.9139 -5.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1908 -5.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.9139 -6.5313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4945 -5.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1908 -6.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4945 -6.5313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.3332 -5.7011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 12.0295 -5.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.5007 -5.3768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 12.7616 -5.6918 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 14.0523 -5.9742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.8438 -6.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.6501 -6.6697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.6577 -4.5704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.4529 -4.3188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1908 -4.4692 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.4945 -4.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1908 -7.7364 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 8.3874 -7.7364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.1908 -8.5665 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.0210 -7.7632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 3 1 1 0 0 0 0 9 1 1 0 0 0 0 4 3 2 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 18 4 1 0 0 0 0 7 5 2 0 0 0 0 8 6 2 0 0 0 0 8 7 1 0 0 0 0 20 7 1 0 0 0 0 10 9 1 0 0 0 0 12 10 1 1 0 0 0 12 11 1 0 0 0 0 13 11 1 0 0 0 0 16 11 1 0 0 0 0 14 12 1 0 0 0 0 15 13 1 0 0 0 0 15 14 1 0 0 0 0 17 16 1 0 0 0 0 19 18 1 0 0 0 0 21 20 2 0 0 0 0 22 20 2 0 0 0 0 23 20 1 0 0 0 0 M END > CHEBI:64119 > (S)-(-)-sulpiride > An optically active form of sulpiride having (S)-configuration. The active enantiomer of the racemic drug sulpiride. Selective D2-like dopamine antagonist (Ki values are ~ 0.015. ~ 0.013, 1, ~ 45 and ~ 77 μM at D2, D3, D4, D1 and D5 receptors respectively). > 3 > S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide; (S)-sulpiride; (S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide; (S)-(-)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide; (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide; (-)-sulpiride > N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide > levosulpiridum; levosulpiride; levosulpirida > C15H23N3O4S > 341.42600 > 341.14093 > 0 > CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O > InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1 > BGRJTUBHPOOWDU-NSHDSACASA-N > 23672-07-3 > 3563418 > 23672-07-3 > DB00391 > D07312 > LSM-5624 > Levosulpiride > 18186115; 19165957; 19452563; 19488984; 19795476; 20438811; 20656570; 20850200; 21223496; 21615988 $$$$